Growing Demand for Advanced Therapies Drives Autoimmune Disease Therapeutics Market Growth
PORTLAND, OREGON, UNITED STATES, March 23, 2023 /EINPresswire.com/ -- Autoimmune diseases occur when the body's immune system mistakenly attacks healthy cells and tissues, leading to inflammation and damage. Autoimmune disease therapeutics are treatments that aim to help manage the symptoms of autoimmune diseases by suppressing or modifying the immune system's activity.
๐๐ก๐๐ซ๐ ๐๐ซ๐ ๐ฌ๐๐ฏ๐๐ซ๐๐ฅ ๐ญ๐ฒ๐ฉ๐๐ฌ ๐จ๐ ๐๐ฎ๐ญ๐จ๐ข๐ฆ๐ฆ๐ฎ๐ง๐ ๐๐ข๐ฌ๐๐๐ฌ๐ ๐ญ๐ก๐๐ซ๐๐ฉ๐๐ฎ๐ญ๐ข๐๐ฌ, ๐ข๐ง๐๐ฅ๐ฎ๐๐ข๐ง๐ :
Immunosuppressants: These drugs work by suppressing the immune system's activity, which can help reduce inflammation and prevent further damage to tissues. Examples include corticosteroids, methotrexate, and cyclophosphamide.
Biologics: Biologics are a type of medication made from living cells that target specific molecules in the immune system. They work by blocking the activity of certain immune cells or proteins that contribute to inflammation. Examples include adalimumab, infliximab, and rituximab.
Disease-modifying antirheumatic drugs (DMARDs): DMARDs are a class of drugs that slow down the progression of autoimmune diseases and reduce joint damage. Examples include methotrexate, sulfasalazine, and leflunomide.
Nonsteroidal anti-inflammatory drugs (NSAIDs): These drugs help reduce pain, swelling, and inflammation in the body. Examples include ibuprofen and naproxen.
Autoimmune disease therapeutics can help manage the symptoms of autoimmune diseases, but they may also have side effects. It is important to work closely with a healthcare provider to find the right treatment plan for each individual.
๐๐ฎ๐ญ๐จ๐ข๐ฆ๐ฆ๐ฎ๐ง๐ ๐๐ข๐ฌ๐๐๐ฌ๐ ๐๐ก๐๐ซ๐๐ฉ๐๐ฎ๐ญ๐ข๐๐ฌ ๐๐๐ซ๐ค๐๐ญ ๐๐ญ๐๐ญ๐ข๐ฌ๐ญ๐ข๐๐ฌ ๐๐๐๐ -
The global autoimmune disease therapeutics market was valued at $109,833 million in 2017, and is expected to reach $153,320 million by 2025, growing at a CAGR of 4.2% from 2018 to 2025.
Recent launch of advanced therapeutics plays a major role in the growth of the autoimmune disease therapeutics market. Furthermore, increase in prevalence of autoimmune disease and strong presence of late stage pipeline drugs are expected to boost the market growth in the coming years.
๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐ญ: https://www.alliedmarketresearch.com/request-sample/5185
Increase in adoption of autoimmune disease therapeutics, surge in wide availability of advanced therapeutics, and rise in number of research and development activities drive the growth in the market. However, high initial costs related to advanced therapeutics restrain the market growth. On the other hand, strong presence of pipeline drugs and opportunities in emerging economies create new pathways in the industry.
๐๐ฎ๐ญ๐จ๐ข๐ฆ๐ฆ๐ฎ๐ง๐ ๐๐ข๐ฌ๐๐๐ฌ๐ ๐ญ๐ก๐๐ซ๐๐ฉ๐๐ฎ๐ญ๐ข๐๐ฌ ๐๐ซ๐ ๐ฎ๐ฌ๐๐ ๐ข๐ง ๐ฌ๐๐ฏ๐๐ซ๐๐ฅ ๐ฌ๐๐ ๐ฆ๐๐ง๐ญ๐ฌ ๐จ๐ ๐ญ๐ก๐ ๐ฉ๐จ๐ฉ๐ฎ๐ฅ๐๐ญ๐ข๐จ๐ง, ๐ข๐ง๐๐ฅ๐ฎ๐๐ข๐ง๐ :
Rheumatology: Rheumatologists are doctors who specialize in the diagnosis and treatment of autoimmune diseases that affect the joints, muscles, and bones, such as rheumatoid arthritis, lupus, and psoriatic arthritis.
Dermatology: Dermatologists may use autoimmune disease therapeutics to treat skin conditions that result from an overactive immune system, such as psoriasis and eczema.
Gastroenterology: Gastroenterologists may use autoimmune disease therapeutics to treat inflammatory bowel diseases (IBD), such as Crohn's disease and ulcerative colitis.
Neurology: Neurologists may use autoimmune disease therapeutics to treat autoimmune diseases that affect the nervous system, such as multiple sclerosis and myasthenia gravis.
Endocrinology: Endocrinologists may use autoimmune disease therapeutics to treat autoimmune diseases that affect the endocrine system, such as type 1 diabetes and Hashimoto's thyroiditis.
Autoimmune disease therapeutics may also be used in other segments of the population depending on the specific autoimmune disease being treated.
๐ ๐จ๐ซ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ง๐ช๐ฎ๐ข๐ซ๐ฒ- https://www.alliedmarketresearch.com/purchase-enquiry/5185
According to sales channel, the market is segmented into hospital pharmacies, drug stores & retail pharmacies, and online stores. Online providers segment is expected to experience rapid growth during the forecast period owing to rise in preference for online purchasing of drugs over the traditional methods and increase in awareness about online pharmacy with rise in number of internet users. On the other side, drug store & retail pharmacy segment is estimated to be the major revenue contributor due to massive presence of these pharmacies.
๐๐ก๐๐ซ๐ ๐๐ซ๐ ๐ฌ๐๐ฏ๐๐ซ๐๐ฅ ๐๐๐๐ญ๐จ๐ซ๐ฌ ๐ญ๐ก๐๐ญ ๐๐๐ง ๐ข๐ฆ๐ฉ๐๐๐ญ ๐๐ฎ๐ญ๐จ๐ข๐ฆ๐ฆ๐ฎ๐ง๐ ๐๐ข๐ฌ๐๐๐ฌ๐ ๐ญ๐ก๐๐ซ๐๐ฉ๐๐ฎ๐ญ๐ข๐๐ฌ, ๐ข๐ง๐๐ฅ๐ฎ๐๐ข๐ง๐ :
Disease Severity: The severity of the autoimmune disease can impact the choice of treatment and the dosage required. More severe cases may require stronger and more aggressive treatments.
Age and Gender: The age and gender of the patient can also impact the choice of treatment. Some autoimmune diseases are more prevalent in certain age groups or genders.
Genetics: Genetics plays a significant role in the development of autoimmune diseases. Some individuals may have a higher risk of developing an autoimmune disease due to their genetic makeup.
Lifestyle Factors: Lifestyle factors such as diet, exercise, and stress can impact the immune system and contribute to the development or exacerbation of autoimmune diseases.
Access to Treatment: Access to healthcare and affordable treatments can impact the ability of individuals to manage their autoimmune diseases effectively.
๐๐๐ ๐ข๐จ๐ง๐๐ฅ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ:
North America accounted for a major market share in 2017, and is expected to remain dominant throughout the forecast period. Higher prevalence of autoimmune disease, early diagnosis, easy availability of advanced therapeutics, strong presence of key players, favorable reimbursement in healthcare system, and higher number of trained medical professionals are key drivers of the North America autoimmune disease therapeutics market. On the other side, Asia-Pacific is expected to experience the highest growth rate during the forecast period owing to increase in number of target population, rise in adoption of therapeutics with development in healthcare infrastructure.
๐๐ฌ๐ค ๐ญ๐จ ๐๐ฎ๐ซ ๐๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐๐ฑ๐ฉ๐๐ซ๐ญ: https://www.alliedmarketresearch.com/connect-to-analyst/5185
๐๐ซ๐จ๐ฆ๐ข๐ง๐๐ง๐ญ ๐ฆ๐๐ซ๐ค๐๐ญ ๐ฉ๐ฅ๐๐ฒ๐๐ซ๐ฌ-
Abbott Laboratories, AbbVie Inc., Amgen Inc., AstraZeneca Plc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd. (Genentech, Inc.,), Johnson & Johnson, Novartis AG, Pfizer Inc., UCB S.A.
๐๐๐จ๐ฎ๐ญ ๐๐ฅ๐ฅ๐ข๐๐ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
Allied Market Research
Allied Market Research
+1 800-792-5285
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn